CorMedix Inc. Announces Scientific Advisory Board to Support Commercialization and Pipeline Development

3 years ago

BERKELEY HEIGHTS, N.J., April 07, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…

BioSig to Present at NobleCon18 Capital Markets Conference

3 years ago

Westport, CT, April 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology…

SmileDirectClub to Report First Quarter 2022 Results on May 9, 2022

3 years ago

NASHVILLE, Tenn., April 07, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the…

Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022

3 years ago

SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein…

Bolt Biotherapeutics to Present at 21st Annual Needham Healthcare Conference

3 years ago

REDWOOD CITY, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new…

38th Edition of the Funds from the Heart Fundraiser

3 years ago

Nearly 300 IGA supermarkets rally for heart healthMONTREAL and QUEBEC CITY, April 07, 2022 (GLOBE NEWSWIRE) -- In collaboration with…

Impel NeuroPharma To Present At The 21st Annual Needham Healthcare Conference

3 years ago

SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people…

Webinar: Piezo Motion’s Miniature Motors Are Driving Next Generation of Medical Devices

3 years ago

On April 21, Dr. Mark Broderick will discuss how Piezo Motion is revolutionizing the miniature-motor industry and providing viable solutions…

Rubius Therapeutics to Host Investor Webcast to Discuss Updated Clinical Data at AACR from the Ongoing Monotherapy Phase 1 Arm of the Phase 1/2 Clinical Trial of RTX-240 in Patients with Advanced Solid Tumors on April 8, 2022, at 1:15 PM ET

3 years ago

CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically…

LifeMD to Participate in the 21st Annual Needham Virtual Healthcare Conference

3 years ago

NEW YORK, April 07, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that…